APPLICATION
ANDA215109
TYPE
ANDA
ORIGINAL APPROVAL
2021-09-23
LATEST ACTION
2026-03-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
VIGABATRINPrescription
VIGABATRIN 500MG · TABLET · ORAL
Approval history
2026-03-18REMS · Supplement 4AP
2024-09-12REMS · Supplement 3AP
2022-10-12REMS · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.